Conduction System Pacing With Left Bundle Branch Pacing as Compared to Standard Right Ventricular Pacing

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMcGill University Health Centre/Research Institute of the McGill University Health Centre

About this trial

High burden right ventricular (RV) pacing has been shown to increase cardiovascular mortality, incidence of heart failure (HF), worsen left ventricular (LV) function and accelerate the development of atrial fibrillation (AF). High percentage ventricular pacing and wider paced QRS in the setting of normal baseline LV ejection fractions have consistently been shown to be independent risk factors for pacing-induced cardiomyopathy. Left bundle branch pacing (LBBP) has emerged as a potential alternative pacing mechanism that may avoid LV dyssynchrony and pacing-induced LV dysfunction by mimicking native electrical conduction.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Patients with an ejection fraction of >35%

Third degree AV block

Symptomatic or asymptomatic second-degree AV block

Disqualifiers

Indication for an implantable cardioverter defibrillator

Presence of a mechanical tricuspid valve

Any prior attempt at implantation of an ICD, CRT, HBP, or LBBP

Lack of capacity to consent

Trial design

Treatments tested in this trial

  • Left bundle branch pacing lead
  • Right ventricular active fixation lead

Treatment groups

1,300 Participants
are divided into 2 treatment groups

Sponsors and collaborators

McGill University Health Centre/Research Institute of the McGill University Health Centre

Lead sponsor

Heart and Stroke Foundation of Canada

Collaborator

Canadian Institutes of Health Research (CIHR)

Collaborator